Differenze in outcome e fallimenti tra allograft e autograft nella revisione del legamento crociato anteriore

Title

Code

ACLREV_GRAFT

Type

Osservazionale

Start Year

2026

Status

In Corso

Principal Investigator

051-6366111 (centralino)

stefano.zaffagnini@unibo.it

Zaffagnini Stefano, MD

Director

2nd Orthopaedic and Traumatologic Clinic

Operational unit that carry out the study

complex unit

Clinica Ortopedica e Traumatologica II

Director

Zaffagnini Stefano, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. ACLREV_GRAFT

Friday 19 June 2026, 15:25

PG0008553_2026_Nulla osta DG_ALCREV_GRAFT - Zaffagnini.pdf

Attachment

Informativa sul trattamento dei dati personali e particolari

Friday 19 June 2026, 15:26

PG0004632_2026_06_informativa_dati_ce-avec_v.1.0.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Differenze in outcome e fallimenti tra allograft e autograft nella revisione del legamento crociato anteriore

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Differenze in outcome e fallimenti tra allograft e autograft nella revisione del legamento crociato anteriore

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in